Psychedelic Therapy US Public Opinion Research Report
Introduction: One emerging area of mental health treatments that has generated much discussion and controversy is Psychedelic Therapy. The use of psychedelic substances in therapeutic settings aims to treat various mental health disorders including depression, PTSD and anxiety; yet its acceptance, perception and knowledge remains variable. This report seeks to provide a comprehensive survey of […]
California Assembly Approves Bill to Decriminalize Psychotropic Substances
In an unprecedented move, the California State Assembly has given its approval for an innovative bill aimed at decriminalizing certain psychedelic substances. Decriminalizing PsychedelicsSenate Bill 58 proposes decriminalization of small amounts of certain naturally occurring psychedelics such as psilocybin mushrooms, Dimethyltryptamine (DMT), and mescaline. Notably excluded is peyote due to concerns regarding its near-endangered status […]
The Decriminalization Wave: Analysis of Recent Legislative Changes to Psychedelic Policy
Recently, there has been an upsurge in interest regarding psychedelic substances and their therapeutic applications. Coupled with research demonstrating their safety and efficacy, this renewed attention has given way to an upsurge in decriminalization efforts across the US and beyond. We will examine recent legislative changes related to psychedelic policy reform as well as investigate […]
Comparing Top Psychedelic Investments Based on Risk, Growth and Profitability
The psychedelic industry has experienced rapid expansion over the last several years due to increased public interest, innovative clinical research, and shifting legal landscapes. Investors are eager to capitalize on psychedelic medicine’s immense potential as well as those companies at the forefront of this burgeoning market; we will compare some of the top investments, taking […]